PPARD and breast carcinoma: In addition, pretreatment with GSK0660 significantly inhibited GW501516-induced expression of ADAMTS1 mRNA (Figure 4F), confirming involvement of PPARδ in GW501516-mediated upregulation of ADAMTS1 in breast cancer cells.